Rejuveron is a clinical-stage biotechnology company creating therapies to improve healthy aging. Here are details of Rejuveron’s latest funding round :
Christian Angermayer, Matthias Steger, Aksana Labokha, Manuel Serrano, Timothy Cash, Lee Rubin, Tristan Heintz, Marianna Feretzaki, Naffi Wade, Malaika Schroeder
💸 Funding & Investors
- Investment (September 2023) : $75 million (Series B)
- Investors : co-led by Catalio Capital Management and Apeiron Investment Group, the family office and private investment firm of entrepreneur Christian Angermayer. The round was also joined by new investor Mubadala Capital, a subsidiary of Mubadala Investment Company.
🎯 Funding purpose
Investment in Boost Neuroscience, a Catalio-backed company developing brain synapse regeneration technologies. And expansion in the Middle East.
🌐 Country HQ